Obesity is a key driver of insulin resistance and the development of type 2 diabetes, and it is also linked to an increased risk of certain cancers. Managing diabetes and obesity in patients with cancer presents unique challenges, as therapeutic goals often extend beyond glycemic control to support cancer treatment outcomes.
This webinar will address the knowledge and practice gaps surrounding the pathophysiology of diabetes in cancer patients and the impact of antineoplastic therapies on diabetes management, helping clinicians refine strategies for this complex patient population.
Dr. Lubaina Presswala, DO, FACE
Dr. James Flory, MD